Fate Therapeutics (FATE) Insider Trading & Ownership

$3.22

0.00 (0.00%)

(As of 01:58 PM ET)

Current Insider Ownership Percentage: 5.00%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $166,023.60
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $202,409.98

Get FATE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FATE Insider Buying and Selling by Quarter

Ad Unstoppable Prosperity

Don’t Buy Another Stock Until Reading This…

Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my upcoming FREE intro to investing online event, my team will be revealing the strategies I've developed over the past 37 years on Wall Street…

Click here to claim your seat at my Intro to Investing class now!

Fate Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/6/2024	Yuan Xu	Director	Sell	633	$4.23	$2,677.59
1/29/2024	Edward J Dulac III	CFO	Sell	1,849	$5.00	$9,245.00
1/9/2024	Bahram Valamehr	Insider	Sell	11,271	$4.38	$49,366.98
1/9/2024	Cindy Tahl	General Counsel	Sell	10,874	$4.37	$47,519.38
1/9/2024	Edward J Dulac III	CFO	Sell	7,028	$4.37	$30,712.36
1/9/2024	J Scott Wolchko	CEO	Sell	14,391	$4.37	$62,888.67
12/26/2023	Redmile Group, Llc	Director	Buy	44,630	$3.72	$166,023.60

(Data available from 1/1/2013 forward)

FATE Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Fate Therapeutics includes Bahram Valamehr, Brian T Powl, Cindy Tahl, Edward J Dulac III, J Scott Wolchko, John Mendlein, Mark Plavsic, Redmile Group, Llc, Shefali Agarwal, Yuan Xu, and Yu-Waye Chu. Learn more on insiders at FATE.
: 5.00% of Fate Therapeutics stock is owned by insiders. Learn more on FATE's insider holdings.
: The following insiders have purchased FATE shares in the last 24 months: John Mendlein ($698,138.49), and Redmile Group, Llc ($440,023.60).
: Insiders have purchased a total of 215,009 FATE shares in the last 24 months for a total of $1,138,162.09 bought.
: The following insiders have sold FATE shares in the last 24 months: Bahram Valamehr ($106,572.06), Brian T Powl ($18,768.98), Cindy Tahl ($108,057.10), Edward J Dulac III ($116,611.26), J Scott Wolchko ($303,441.35), Yuan Xu ($24,329.11), and Yu-Waye Chu ($16,635.24).
: Insiders have sold a total of 142,132 Fate Therapeutics shares in the last 24 months for a total of $694,415.10 sold.